+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Connected Drug Delivery Devices Market by Device Type (Infusion Pumps, Inhalers, Injection Devices), Drug Type (Biologics, Biosimilars, Small Molecule), End User, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 187 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6014742
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The connected drug delivery devices market is undergoing a significant transformation as connectivity reshapes therapeutic administration, patient adherence, and healthcare operations. This detailed analysis is designed for senior decision-makers seeking actionable insights into how connected technologies are redefining drug delivery across clinical and home settings.

Market Snapshot: Connected Drug Delivery Devices

The Connected Drug Delivery Devices Market grew from USD 966.22 million in 2024 to USD 1.11 billion in 2025. It is expected to continue growing at a CAGR of 14.68%, reaching USD 2.19 billion by 2030. This growth is propelled by real-time patient monitoring, adaptive dosing, and integration with digital health ecosystems across hospitals and home care environments. Increased regulatory support and expanding collaborations between pharmaceutical and medtech firms are further accelerating the adoption of smart pumps, inhalers, and intelligent injection systems.

Scope & Segmentation: Future-Ready Insights

  • Device Types: Infusion pumps, including enteral, insulin, and PCA models; inhalers, such as dry powder, metered dose, and nebulizer systems; injection devices, including autoinjectors, pen injectors, safety syringes, and standard syringes; nasal spray, with both manual and nebulized forms; transdermal patch, comprising matrix and reservoir variants.
  • Drug Types: Biologics, biosimilars, small molecule therapies, and vaccines with increasing attention to cold chain monitoring and digital packaging.
  • End Users: Hospitals, home care, ambulatory care centers, and clinics, each with distinct integration and usability priorities.
  • Distribution Channels: Direct sales, hospital, retail, and online pharmacies, all exploring value-added services and device-patient pairing solutions.
  • Geographic Regions: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including the UK, Germany, France, and others), and Asia-Pacific (China, India, Japan, Australia, South Korea, Southeast Asia markets).
  • Technologies: Cloud-based analytics, AI-enabled algorithms, sensor miniaturization, interoperability protocols, modular architectures, and cybersecurity measures supporting robust, scalable implementations.

Key Takeaways for Decision Makers

  • Connectivity is transforming drug delivery by enabling actionable insights through continuous adherence monitoring and physiological data analytics.
  • Rapid innovation is being driven by advances in artificial intelligence, sensor fusion, and open communication standards, streamlining device integration with wider healthcare IT ecosystems.
  • Manufacturers leveraging modular platforms and strong cloud-service partnerships can accelerate customization and maintain robust cybersecurity compliance as digital health standards evolve.
  • Regulatory bodies are issuing new frameworks that encourage interoperability and require demonstrable safety enhancements in connected devices.
  • Regional adoption trends diverge: North America and Asia-Pacific prioritize telehealth and scalable digital ecosystems, while EMEA addresses reimbursement and infrastructure diversity.
  • Strategic collaborations between OEMs, payers, and technology providers are underpinning the shift towards outcome-based reimbursement models tied to real-world evidence.

Tariff Impact: 2025 United States Revisions

The 2025 revision of United States tariffs targeting electronic components and finished drug delivery devices has compelled industry players to revisit sourcing and supply chain strategies. Elevated import costs have driven reassessment of overseas contracts and intensified interest in domestic or near-shore manufacturing. This policy change has catalyzed investment in regional suppliers and prompted companies to explore alternative semiconductor sources and logistics pathways. The resulting realignment is also fostering innovation around the localization of assembly and regulatory-driven infrastructure investments.

Methodology & Data Sources

This report combines comprehensive primary interviews with clinicians, device manufacturers, and supply chain experts, along with in-depth secondary research drawn from peer-reviewed publications and regulatory filings. Data triangulation and structured market modeling ensure accurate segmentation and unbiased analysis of pricing, supply chain, and innovation trends.

Why This Report Matters

  • Enables informed decision making by delivering actionable intelligence on emerging technologies, regulatory influences, and end-user requirements in connected drug delivery.
  • Provides an in-depth understanding of evolving reimbursement frameworks and the regional forces shaping adoption across primary global markets.
  • Equips stakeholders with strategic foresight to optimize supply chain resilience, operational efficiency, and competitive positioning in a rapidly maturing sector.

Conclusion

Connected drug delivery devices are set to play an integral role in supporting therapy adherence and operational efficiency across global healthcare systems. Organizations prepared to harness technological convergence and patient-centric design will realize competitive advantages as the market progresses.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of AI-driven predictive algorithms into insulin pens for personalized dosage adjustments
5.2. Adoption of real-time wireless monitoring platforms for chemotherapy infusion adherence tracking
5.3. Implementation of Bluetooth-enabled smart inhalers for remote patient respiratory data collection
5.4. Development of NFC based medication authentication features to prevent counterfeit injectable drugs
5.5. Expansion of cloud-based analytics dashboards for clinicians monitoring patient drug delivery metrics
5.6. Emergence of smartphone app ecosystems enabling two-way communication with implantable drug pumps
5.7. Integration of blockchain ledgers into connected drug delivery to enhance data security and traceability
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Connected Drug Delivery Devices Market, by Device Type
8.1. Introduction
8.2. Infusion Pumps
8.2.1. Enteral Pumps
8.2.2. Insulin Pumps
8.2.3. PCA Pumps
8.3. Inhalers
8.3.1. Dry Powder Inhalers
8.3.2. Metered Dose Inhalers
8.3.3. Nebulizers
8.4. Injection Devices
8.4.1. Autoinjectors
8.4.2. Pen Injectors
8.4.3. Safety Syringes
8.4.4. Standard Syringes
8.5. Nasal Spray
8.5.1. Manual Spray
8.5.2. Nebulized Spray
8.6. Transdermal Patch
8.6.1. Matrix Patch
8.6.2. Reservoir Patch
9. Connected Drug Delivery Devices Market, by Drug Type
9.1. Introduction
9.2. Biologics
9.3. Biosimilars
9.4. Small Molecule
9.5. Vaccines
10. Connected Drug Delivery Devices Market, by End User
10.1. Introduction
10.2. Ambulatory Care Centers
10.3. Clinics
10.4. Home Care
10.5. Hospitals
11. Connected Drug Delivery Devices Market, by Distribution Channel
11.1. Introduction
11.2. Direct Sales
11.3. Hospital Pharmacy
11.4. Online Pharmacy
11.5. Retail Pharmacy
12. Americas Connected Drug Delivery Devices Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Connected Drug Delivery Devices Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Connected Drug Delivery Devices Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Medtronic plc
15.3.2. Becton, Dickinson and Company
15.3.3. Baxter International Inc.
15.3.4. Roche Holding AG
15.3.5. Smiths Group plc
15.3.6. Insulet Corporation
15.3.7. Tandem Diabetes Care, Inc.
15.3.8. Ypsomed Holding AG
15.3.9. Novo Nordisk A/S
15.3.10. Sanofi S.A.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. CONNECTED DRUG DELIVERY DEVICES MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. CONNECTED DRUG DELIVERY DEVICES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. CONNECTED DRUG DELIVERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. CONNECTED DRUG DELIVERY DEVICES MARKET: RESEARCHAI
FIGURE 24. CONNECTED DRUG DELIVERY DEVICES MARKET: RESEARCHSTATISTICS
FIGURE 25. CONNECTED DRUG DELIVERY DEVICES MARKET: RESEARCHCONTACTS
FIGURE 26. CONNECTED DRUG DELIVERY DEVICES MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. CONNECTED DRUG DELIVERY DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY ENTERAL PUMPS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY ENTERAL PUMPS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INSULIN PUMPS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INSULIN PUMPS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PCA PUMPS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PCA PUMPS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRY POWDER INHALERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRY POWDER INHALERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY METERED DOSE INHALERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY METERED DOSE INHALERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY AUTOINJECTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY AUTOINJECTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PEN INJECTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PEN INJECTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY SAFETY SYRINGES, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY SAFETY SYRINGES, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY STANDARD SYRINGES, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY STANDARD SYRINGES, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY MANUAL SPRAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY MANUAL SPRAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZED SPRAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZED SPRAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY MATRIX PATCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY MATRIX PATCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY RESERVOIR PATCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY RESERVOIR PATCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY BIOLOGICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY BIOSIMILARS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY BIOSIMILARS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY SMALL MOLECULE, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY SMALL MOLECULE, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY HOME CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 129. CANADA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 130. CANADA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 131. CANADA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2024 (USD MILLION)
TABLE 132. CANADA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2025-2030 (USD MILLION)
TABLE 133. CANADA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, 2018-2024 (USD MILLION)
TABLE 134. CANADA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, 2025-2030 (USD MILLION)
TABLE 135. CANADA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2024 (USD MILLION)
TABLE 136. CANADA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2025-2030 (USD MILLION)
TABLE 137. CANADA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2024 (USD MILLION)
TABLE 138. CANADA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2025-2030 (USD MILLION)
TABLE 139. CANADA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, 2018-2024 (USD MILLION)
TABLE 140. CANADA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, 2025-2030 (USD MILLION)
TABLE 141. CANADA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 142. CANADA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 143. CANADA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 144. CANADA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 145. CANADA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 146. CANADA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 147. MEXICO CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 148. MEXICO CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 149. MEXICO CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2024 (USD MILLION)
TABLE 150. MEXICO CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2025-2030 (USD MILLION)
TABLE 151. MEXICO CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, 2018-2024 (USD MILLION)
TABLE 152. MEXICO CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, 2025-2030 (USD MILLION)
TABLE 153. MEXICO CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2024 (USD MILLION)
TABLE 154. MEXICO CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2025-2030 (USD MILLION)
TABLE 155. MEXICO CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2024 (USD MILLION)
TABLE 156. MEXICO CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2025-2030 (USD MILLION)
TABLE 157. MEXICO CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, 2018-2024 (USD MILLION)
TABLE 158. MEXICO CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, 2025-2030 (USD MILLION)
TABLE 159. MEXICO CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 160. MEXICO CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 161. MEXICO CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 162. MEXICO CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 163. MEXICO CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 164. MEXICO CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 183. ARGENTINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 184. ARGENTINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 185. ARGENTINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2024 (USD MILLION)
TABLE 186. ARGENTINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2025-2030 (USD MILLION)
TABLE 187. ARGENTINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, 2018-2024 (USD MILLION)
TABLE 188. ARGENTINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, 2025-2030 (USD MILLION)
TABLE 189. ARGENTINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2024 (USD MILLION)
TABLE 190. ARGENTINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2025-2030 (USD MILLION)
TABLE 191. ARGENTINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2024 (USD MILLION)
TABLE 192. ARGENTINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2025-2030 (USD MILLION)
TABLE 193. ARGENTINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, 2018-2024 (USD MILLION)
TABLE 194. ARGENTINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2024 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2025-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, 2018-2024 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2025-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2024 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2025-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, 2018-2024 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, 2025-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 221. UNITED KINGDOM CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 222. UNITED KINGDOM CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 223. UNITED KINGDOM CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2024 (USD MILLION)
TABLE 224. UNITED KINGDOM CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2025-2030 (USD MILLION)
TABLE 225. UNITED KINGDOM CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, 2018-2024 (USD MILLION)
TABLE 226. UNITED KINGDOM CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, 2025-2030 (USD MILLION)
TABLE 227. UNITED KINGDOM CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2024 (USD MILLION)
TABLE 228. UNITED KINGDOM CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2025-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2024 (USD MILLION)
TABLE 230. UNITED KINGDOM CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2025-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, 2018-2024 (USD MILLION)
TABLE 232. UNITED KINGDOM CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, 2025-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 234. UNITED KINGDOM CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 236. UNITED KINGDOM CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 238. UNITED KINGDOM CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 239. GERMANY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 240. GERMANY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 241. GERMANY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2024 (USD MILLION)
TABLE 242. GERMANY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2025-2030 (USD MILLION)
TABLE 243. GERMANY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, 2018-2024 (USD MILLION)
TABLE 244. GERMANY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, 2025-2030 (USD MILLION)
TABLE 245. GERMANY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2024 (USD MILLION)
TABLE 246. GERMANY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2025-2030 (USD MILLION)
TABLE 247. GERMANY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2024 (USD MILLION)
TABLE 248. GERMANY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2025-2030 (USD MILLION)
TABLE 249. GERMANY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, 2018-2024 (USD MILLION)
TABLE 250. GERMANY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, 2025-2030 (USD MILLION)
TABLE 251. GERMANY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 252. GERMANY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 253. GERMANY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. GERMANY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. GERMANY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 256. GERMANY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 257. FRANCE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 258. FRANCE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 259. FRANCE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2024 (USD MILLION)
TABLE 260. FRANCE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2025-2030 (USD MILLION)
TABLE 261. FRANCE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, 2018-2024 (USD MILLION)
TABLE 262. FRANCE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, 2025-2030 (USD MILLION)
TABLE 263. FRANCE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2024 (USD MILLION)
TABLE 264. FRANCE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2025-2030 (USD MILLION)
TABLE 265. FRANCE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2024 (USD MILLION)
TABLE 266. FRANCE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2025-2030 (USD MILLION)
TABLE 267. FRANCE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, 2018-2024 (USD MILLION)
TABLE 268. FRANCE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, 2025-2030 (USD MILLION)
TABLE 269. FRANCE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 270. FRANCE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 271. FRANCE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 272. FRANCE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 273. FRANCE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 274. FRANCE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 275. RUSSIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 276. RUSSIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 277. RUSSIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2024 (USD MILLION)
TABLE 278. RUSSIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2025-2030 (USD MILLION)
TABLE 279. RUSSIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, 2018-2024 (USD MILLION)
TABLE 280. RUSSIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, 2025-2030 (USD MILLION)
TABLE 281. RUSSIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2024 (USD MILLION)
TABLE 282. RUSSIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2025-2030 (USD MILLION)
TABLE 283. RUSSIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2024 (USD MILLION)
TABLE 284. RUSSIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2025-2030 (USD MILLION)
TABLE 285. RUSSIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, 2018-2024 (USD MILLION)
TABLE 286. RUSSIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, 2025-2030 (USD MILLION)
TABLE 287. RUSSIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 288. RUSSIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 289. RUSSIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 290. RUSSIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 291. RUSSIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 292. RUSSIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 293. ITALY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 294. ITALY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 295. ITALY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2024 (USD MILLION)
TABLE 296. ITALY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2025-2030 (USD MILLION)
TABLE 297. ITALY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, 2018-2024 (USD MILLION)
TABLE 298. ITALY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, 2025-2030 (USD MILLION)
TABLE 299. ITALY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2024 (USD MILLION)
TABLE 300. ITALY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2025-2030 (USD MILLION)
TABLE 301. ITALY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Connected Drug Delivery Devices market report include:
  • Medtronic plc
  • Becton, Dickinson and Company
  • Baxter International Inc.
  • Roche Holding AG
  • Smiths Group plc
  • Insulet Corporation
  • Tandem Diabetes Care, Inc.
  • Ypsomed Holding AG
  • Novo Nordisk A/S
  • Sanofi S.A.

Table Information